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Abstract 
Background: Inertial measurement unit (IMU)-based motion capture systems are 
gaining popularity for gait analysis outside laboratories. It is important to determine 
the performance of such systems in specific patient populations. We aimed to validate 
and determine within-day reliability of an IMU system for measuring lower limb gait 
kinematics and temporal–spatial parameters (TSP) in people with and without HIV.
Methods: Gait was recorded in eight adults with HIV (PLHIV) and eight HIV-seron-
egative participants (SNP), using IMUs and optical motion capture (OMC) simultane-
ously. Participants performed six gait trials. Fifteen TSP and 28 kinematic angles were 
extracted. Intraclass correlations (ICC), root-mean-square error (RMSE), mean absolute 
percentage error and Bland–Altman analyses were used to assess concurrent validity 
of the IMU system (relative to OMC) separately in PLHIV and SNP. IMU reliability was 
assessed during within-session retest of trials. ICCs were used to assess relative reli-
ability. Standard error of measurement (SEM) and percentage SEM were used to assess 
absolute reliability.
Results: Between-system TSP differences demonstrated acceptable-to-excellent ICCs 
(0.71–0.99), except for double support time and temporophasic parameters (< 0.60). All 
TSP demonstrated good mean absolute percentage errors (≤7.40%). For kinematics, 
ICCs were acceptable to excellent (0.75–1.00) for all but three range of motion (ROM) 
and four discrete angles. RMSE and bias were 0.0°–4.7° for all but two ROM and 10 dis-
crete angles. In both groups, TSP reliability was acceptable to excellent for relative (ICC 
0.75–0.99) (except for one temporal and two temporophasic parameters) and absolute 
(%SEM 1.58–15.23) values. Reliability trends of IMU-measured kinematics were similar 
between groups and demonstrated acceptable-to-excellent relative reliability (ICC 
0.76–0.99) and clinically acceptable absolute reliability (SEM 0.7°–4.4°) for all but two 
and three discrete angles, respectively. Both systems demonstrated similar magnitude 
and directional trends for differences when comparing the gait of PLHIV with that of 
SNP.
Conclusions: IMU-based gait analysis is valid and reliable when applied in PLHIV; 
demonstrating a sufficiently low precision error to be used for clinical interpretation 
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(< 5° for most kinematics; < 20% for TSP). IMU-based gait analysis is sensitive to subtle 
gait deviations that may occur in PLHIV.
Keywords: Gait analysis, Kinematics, Temporospatial parameters, Inertial motion 
capture, Inertial measurement units, Reliability, Validity, Measurement error, HIV 
infection
Background
Ever since the first definition of HIV/AIDS in the 1980s, motor impairments were noted 
and described as defining characteristics of the disease [1]. Unfortunately, motor func-
tion remains compromised in people living with HIV (PLHIV) even in the current era of 
modern antiretroviral therapy (ART) [2]. The HI-virus itself, ART drug toxicity, interac-
tions between various comorbidities, traditional risk factors and synergistic mechanisms 
to usual aging may all contribute to the observed impairments. Common impairments 
include muscle weakness and dynapenia [3], peripheral sensory neuropathies [4], motor 
slowing and postural imbalance associated with white matter alterations [5]. Further-
more, a state of ongoing inflammation or immune activation may cause PLHIV to expe-
rience non-AIDS-defining complications resembling geriatric processes (including falls 
and fractures) at relatively young ages [6].
Indeed, about one-third of young- to middle-aged PLHIV experience falls [7, 8] and 
relatively young PLHIV seem to have walking impairments resembling fall-predisposing 
gait characteristics in older adults [9]. However, the true gait pattern in PLHIV remains 
inconclusive, as the gait characteristics that have been assessed are limited to gait speed, 
cadence and gait initiation time (slowed gait speed being the most consistent obser-
vation, while delayed fast gait initiation time and low cadence have been described in 
PLHIV who are also obese) [9]. Furthermore, these observations remain limited to semi-
quantitative clinical assessments, meaning that subtle and early impairments in a young 
population may remain undocumented.
There is currently no evidence from three-dimensional (3D) gait analysis describ-
ing the gait patterns of PLHIV. This situation prohibits a sensitive evaluation of move-
ment quality and level of impairment and therefore little understanding of the impact 
of potential impairments remains. Despite the many parallels that have been drawn 
between usual aging and the processes associated with HIV disease or treatment (e.g., 
telomere shortening, increased interleukin-6, reduced bone mineral density), it must be 
noted that the etiological patterns of chronological aging likely differ from accelerated 
or accentuated aging due to HIV and/or ART. Different patterns of impairment or func-
tional decline may manifest in younger adults dealing with complex chronic illnesses 
(such as HIV) and the associated treatment burden compared to the general popula-
tion of older adults [10]. As the effective, targeted rehabilitation of gait function largely 
depends on an understanding of the underlying impairments and their interactions, 
there is a need to more rigorously investigate the gait patterns that may be unique to 
PLHIV.
Instrumented motion analysis provides 3D data that are accurate and precise. Such 
quantitative data can more comprehensively describe gait patterns and (even subtle) 
impairments; supporting clinical decision-making and allowing for early diagnosis and 
intervention [11]. Although marker-based optical motion capture (OMC) remains the gold 
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standard for human motion capture, inertial motion capture systems are increasingly used 
for 3D gait analysis in various settings outside of the gait laboratory. Inertial motion cap-
ture offers several pragmatic benefits relative to OMC. Such systems are more compact, 
affordable, portable and user-friendly; making them ideal for use in clinical environments 
[12]. Inertial motion capture is based on small yet powerful integrated circuits (inertial 
measurement units or IMUs); typically comprising on-board tri-axial gyroscopes, tri-axial 
magnetometers and tri-axial accelerometers. Using sensor fusion techniques, the ability of 
IMUs to accurately track orientation has become advanced [13].
However, IMU output is body-referenced (i.e., absolute skeletal position is not read-
ily available to IMUs), suffers from drifts and ferromagnetic disturbances that need cor-
rection [14], and often uses automated processing of measured data to generate time and 
space parameters (TSP). The user may not be able to interfere in such processing. It is thus 
important to determine the validity of automatically calculated gait events such as initial 
contact and toe-off, which are important for determining gait phases and other TSP and for 
understanding joint motion at specific points and phases of the gait cycle [15].
Although the validity and reliability of IMUs have been investigated in healthy par-
ticipants and certain patient groups, underlying assumptions and body models may not 
be the same for other population groups or pathologies [16]. IMU validity and reliability 
should thus be demonstrated in the condition of intended use [16] to improve the qual-
ity of data collection and interpretation. Since the 3D gait patterns of PLHIV have never 
been reported, it remains unknown which biomechanical impairments they might dem-
onstrate and validation in this population is therefore warranted. In addition, although a 
recent review [17] reported that IMUs are valid for assessing whole body range of motion 
(ROM), evidence for reliability is lacking and there is a paucity of studies reporting on com-
prehensive, clinically relevant gait outcomes [18]. This study therefore aimed to determine 
the concurrent validity of an IMU system (versus OMC and the Conventional Gait Model 
as reference standard), and the within-session, between-trial reliability of IMUs for meas-
uring lower limb kinematic and temporospatial gait outcomes in PLHIV and HIV-seron-
egative participants (SNP). The study further aimed to determine whether a gait analysis 
conducted using IMUs would differentiate between gait outcomes of PLHIV and SNP in a 
similar manner to a gait analysis conducted using OMC.
Results
The full set of data for all participants (n = 8 PLHIV and n = 8 SNP) were analyzed for both 
the IMU and OMC systems (a total of 96 gait trials for each system). IMU-detected gait 
events (initial contact and toe-off) demonstrated differences from OMC-detected events 
as follows: initial contact errors for IMUs demonstrated median (interquartile range [IQR]) 
values of − 10.00 ms (96.25 ms) in SNP and − 7.50 ms (82.50 ms) in PLHIV. Median (IQR) 
toe-off errors for IMUs were 2.50 ms (95.00 ms) in SNP and − 5.00 ms (62.5 ms) in PLHIV.
Concurrent validity: temporal, spatial, temporophasic and temporospatial parameters 
(TSP)
Between-system differences for TSP demonstrated acceptable-to-excellent intraclass 
correlation coefficients (ICCs, 0.71–0.99), except for double support time and tempo-
rophasic parameters, which demonstrated questionable to poor ICCs (< 0.60) (Fig.  1). 
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All TSP demonstrated good mean absolute percentage errors (≤ 7.40%). RMSE, bias and 
limits of agreement (LoA) between IMUs and OMC were close to zero for temporal, 
leg length-normalized spatial and temporospatial parameters in both participant groups. 
Mean absolute percentage errors were < 2.68% for all parameters except double support 
time (7.40% and 5.79% for SNP and PLHIV, respectively) and double support percent-
age (6.96% and 5.69% for SNP and PLHIV, respectively). These latter parameters had the 
largest mean absolute percentage errors in both groups (Table 1). 
Concurrent validity: kinematics
For kinematics, ICCs were acceptable to excellent (0.75–1.00) for all but three ROM 
and four discrete angles (Fig. 1). RMSE and bias were 0.0°–4.7° for all but two ROM and 
10 discrete angles. RMSE, biases and LoA were generally larger in PLHIV (although 
remaining within 2° from those observed in SNP). Between-system differences were 
< 5° for all ROM outcomes; except for hip internal rotation (both groups) and hip flex-
ion [in PLHIV: ROM over entire gait cycle (i.e., between two successive occurrences of 
ipsilateral initial contact) and ROM from pre-swing to initial swing (i.e., from contralat-
eral initial contact to the instant when the ipsilateral swing leg is adjacent to the stance 
limb)], while angular values at specific time points of the gait cycle tended to exceed 5° 
(Table 2).
Within‑session, between‑trial reliability: TSP
In both participant groups, TSP reliability was acceptable to excellent for relative val-
ues (ICC 0.75–0.99) (except for stance time and percentage in SNP and single support 
percentage in both groups) (Fig. 2) as well as for absolute values [percentage standard 
error of measurement (%SEM) 1.58–15.23]. Spatial parameters showed better absolute 
reliability in SNP [lower standard error of measurement (SEM), %SEM and upper 95% 
confidence limit (CL)], temporal and temporophasic parameters were more reliable in 
PLHIV and temporospatial parameters were more reliable in SNP. However, for all these 
outcomes,  %SEM observed in the two participant groups were within ~ 2% of each other 
(Table 3).
Within‑session, between‑trial reliability: kinematic angles
The reliability of IMU-measured kinematic angles was similar between participant 
groups and demonstrated acceptable-to-excellent relative reliability (ICC 0.76–0.99, 
except for pelvis rotation at initial contact and peak knee flexion during stance) (Fig. 2). 
Clinically acceptable absolute reliability was demonstrated (SEM 0.7°–4.4°) for all but 
three discrete angles (Table 4). In SNP, pelvis rotation at initial contact and ankle plan-
tarflexion angle at toe-off were the only angles with absolute reliability exceeding 5°, 
while in PLHIV, peak knee flexion in stance showed an SEM of 5.8°, with an upper 95% 
CL of 7.0°.
Between‑group comparisons (performed separately for IMU and OMC)
Between-group differences are presented here to demonstrate the validity of a clini-
cal gait assessment by both instrumented systems. Selected kinematic gait curves for 
both groups and systems are presented in Fig.  3 (only sagittal plane traces shown). 
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Directional trends of between-group differences were largely similar in IMU and 
OMC results for TSP (Table  5) and kinematics angles (Table  6). For TSP, between-
group differences and p-values were almost identical for both systems, but less so for 






































































































































































































































































































































































































































































People living with HIV
Fig. 1 Validity of gait parameters and kinematics measured by inertial measurement units (relative to optical 
motion capture). Error bars indicate 95% confidence intervals
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Table 1 Concurrent validity of  gait parameters measured by  inertial measurement units 
(relative to optical motion capture)
MAPE mean absolute percentage error, GC gait cycle, LoA limits of agreement, PLHIV people living with HIV-1 infection, RMSE 
root-mean-square error, SNP HIV-seronegative participants
Parameter RMSE, 
mean (SD)
MAPE, % Bias LoA RMSE, 
mean (SD)
MAPE, % Bias LoA
SNP PLHIV
Spatial parameters
 Step length 
(cm)




0.04 (0.02) 1.66 − 0.01 − 0.07; 0.04 0.05 (0.02) 1.07 − 0.01 − 0.05; 0.04
 Stride 
length









6.93 (4.41) 0.39 0.49 − 5.55; 6.54 6.15 (4.86) 0.18 0.01 − 4.75; 5.00
 Stance 
time (s)
0.02 (0.01) 1.22 0.01 − 0.03; 0.04 0.03 (0.02) 1.06 0.01 − 0.04; 0.05
 Step time 
(s)

























3.01 (1.14) 6.96 1.14 − 3.58; 5.86 2.68 (2.29) 5.69 1.18 − 4.14; 6.51
Temporospatial parameters
 Gait speed 
(m/s)




0.01 (0.01) 2.68 − 0.01 − 0.04; 0.01 0.01 (0.01) 2.13 − 0.01 − 0.03; 0.02
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Table 2 Concurrent validity of kinematic angles measured by inertial measurement units 
(relative to optical motion capture)
A1 corresponding to A1 power phase of ankle, A2 corresponding to A2 power phase of ankle, CI confidence interval, 
H3 corresponding to H3 power phase of hip, HR heel rise, IC initial contact, ICC intraclass correlation coefficient, K1 
corresponding to K1 power phase of knee, K2 corresponding to K2 power phase of knee, K3 corresponding to K3 power 
phase of knee, LoA limits of agreement, LR loading response, MSt mid-stance, PLHIV people living with HIV-1-infection, RMSE 
root-mean-square error, SNP HIV-seronegative participants
Angle/ROM (degrees) RMSE, mean (SD) Bias LoA RMSE, mean (SD) Bias LoA
SNP PLHIV
Pelvis
 Pelvis tilt ROM 2.1 (1.1) 2.0 − 0.1; 4.1 2.9 (1.8) 2.2 − 2.2; 6.5
 Peak anterior pelvis tilt 10.2 (7.1) − 10.1 − 24.4; 4.2 12.5 (5.9) − 12.5 − 24.2; − 0.8
 Pelvis obliquity ROM 2.4 (1.7) − 0.6 − 6.2; 5.0 4.7 (3.3) 1.7 − 9.3; 12.7
 Pelvis rotation ROM 3.3 (1.7) 3.0 − 0.6; 6.6 4.1 (2.4) 3.7 − 1.2; 8.6
 Pelvis rotation, IC 5.5 (2.0) 1.2 − 1.0; 3.5 5.7 (4.5) 2.2 − 1.0; 5.5
Hip
 Hip flexion ROM 3.5 (1.1) − 3.1 − 6.0; − 0.2 5.5 (2.1) − 5.0 − 9.1; − 1.0
 Hip flexion ROM, LR 1.9 (1.5) 0.5 − 1.3; 2.3 2.3 (1.3) 1.3 − 2.0; 4.6
 Hip flexion ROM, PS to 
IS (H3)
3.1 (1.4) < 0.0 − 5.2; 5.1 5.1 (4.4) − 1.6 − 10.4; 7.2
 Hip flexion, IC 8.7 (5.1) − 5.4 − 22.0; 11.3 10.6 (4.5) − 9.4 − 22.1; 3.4
 Peak hip flexion, swing 7.8 (4.8) − 3.7 − 20.1; 12.7 10.0 (4.4) − 9.0 − 21.0; 3.0
 Peak hip extension, 
stance
7.3 (3.9) 0.6 − 16.0; 17.1 6.7 (3.7) 4.0 − 8.8; 16.7
 Hip abduction ROM, MSt 3.2 (1.7) < 0.0 − 5.3; 5.4 4.5 (3.1) 3.3 − 3.1; 9.6
 Hip adduction ROM, LR 3.2 (1.4) 2.8 − 0.1; 5.6 2.9 (1.9) 2.5 − 1.4; 6.3
 Hip internal rotation 
ROM
5.2 (1.4) 1.7 − 6.0; 9.5 5.7 (3.3) 2.7 − 6.7; 12.1
Knee
 Knee flexion ROM 2.2 (0.9) 0.4 − 3.1; 3.9 3.0 (1.5) 1.4 − 3.3; 6.0
 Knee flexion ROM, 
stance (K1)
2.8 (1.3) 1.6 − 1.9; 5.1 1.9 (1.7) 0.7 − 2.0; 3.4
 Knee flexion ROM, 
stance to swing (K3)
2.5 (1.3) − 1.7 − 5.1; 1.6 2.6 (1.3) − 1.5 − 5.5; 2.5
 Knee extension ROM, 
MSt to TSt (K2)
2.5 (1.3) − 2.1 − 4.9; 0.7 3.4 (1.8) − 3.0 − 6.7; 0.6
 Knee flexion, IC 7.8 (1.9) 5.8 − 2.2; 13.7 4.8 (3.3) 2.2 − 6.3; 10.7
 Peak knee flexion, stance 15.3 (7.5) 14.2 − 0.4; 28.8 11.0 (7.5) 9.8 − 5.5; 25.0
 Peak knee extension, 
stance
9.3 (2.8) − 8.3 − 1.1; − 15.5 5.3 (4.0) − 4.0 − 12.5; 4.6
 Peak knee flexion, swing 8.5 (2.5) 7.6 1.2; 14.1 5.4 (3.6) 4.1 − 4.1; 12.3
Ankle
 Ankle dorsiflexion ROM, 
stance (A1)
2.7 (1.1) 2.0 − 1,1; 5.2 2.7 (0.7) 1.7 − 1.5; 4.9
 Ankle dorsiflexion ROM, 
swing
2.3 (1.8) 1.1 − 3.3; 5.4 2.4 (1.0) 1.1 − 2.3; 4.6
 Ankle plantarflexion 
ROM, push off (A2)
2.6 (1.7) 0.5 − 4.8; 5.8 3.4 (1.6) 2.2 − 2.7; 7.1
 Ankle dorsiflexion, IC 3.6 (1.7) − 2.8 − 7.3; 1.7 5.5 (1.8) − 4.6 − 10.8; 1.6
 Ankle plantarflexion, TO 4.1 (1.3) 1.9 − 4.1; 7.9 6.1 (3.3) 5.1 − 1.7; 11.8
 Peak ankle plantarflexion 4.3 (2.1) 1.1 − 6.9; 9.2 5.4 (2.9) 4.6 − 2.7; 11.9
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increased stance- and double-support times, as well as a clinically (but not statisti-
cally) significantly slowed gait speed (> 0.1 m/s). For kinematics, in terms of clinical 
significance (differences > 5°), both systems demonstrated reduced values in PLHIV 








































































































































































































































































































































































































































































People living with HIV
Fig. 2 Relative reliability of gait parameters and kinematics measured by inertial measurement units. Error 
bars indicate 95% confidence intervals
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Discussion
This study assessed the validity and reliability of 3D gait analyses in PLHIV and commu-
nity-matched SNP using a body-worn IMU system relative to a camera-based OMC sys-
tem. PLHIV are suggested to suffer subtle gait impairments that may predispose them to 
adverse functional outcomes. This is the first study to suggest the use of IMUs in PLHIV 
for measuring a comprehensive set of clinically relevant gait outcomes as a reliable alter-
native to OMC. In both participant groups, and for most outcomes, the validity (esti-
mated by between-system comparison) and reliability (estimated from repeated testing) 
of IMU-measured TSP and lower limb angles were deemed acceptable for detecting 
clinically meaningful differences [20]. In terms of absolute reliability, i.e., measurement 
error, all 43 gait analysis outcomes were clinically acceptable, except three discrete kine-
matic angles (pelvis rotation at initial contact, peak knee flexion during stance and ankle 
plantarflexion at toe-off). In terms of gait analysis, IMU technology seems sufficiently 
sensitive to determine gait deviations between PLHIV and SNP.
The IMU and OMC systems demonstrated good agreement, small offsets and accept-
able-to-excellent ICCs for all TSP, although less so for double support time and param-
eters expressed as a percentage of the gait cycle. These findings are similar to those from 
other validation studies investigating various IMU configurations and reference systems 
[18, 21–23]. In addition, the observed initial contact and toe-off errors of 0.010 s or less 
are similar to those that have been reported for IMU systems using smaller recording 
frequencies and different event-detection algorithms [18, 24].
Table 3 Absolute reliability (measurement error) of gait parameters measured by inertial 
measurement units
SEM 95% CL were calculated using a sample-and-trial-specific multiplying factor of 1.2 [19]
%SEM absolute percentage SEM, CL confidence limits of SEM, GC gait cycle, PLHIV people living with HIV-1 infection, SEM 
standard error of measurement, SNP HIV-seronegative participants
Parameter SEM %SEM Upper 95% CL SEM %SEM Upper 95% CL
SNP PLHIV
Spatial parameters
 Step length (cm) 4.01 6.09 4.81 4.33 6.82 5.20
 Normalized step length 0.04 5.20 0.05 0.05 6.98 0.06
 Stride length (cm) 3.20 2.46 3.84 4.03 3.23 4.84
 Normalized stride length 0.04 2.65 0.05 0.05 3.56 0.06
Temporal parameters
 Cadence (steps/min) 8.31 7.08 9.97 9.67 8.82 11.60
 Normalized cadence 2.45 7.04 2.94 2.83 8.57 3.40
 Stance time (s) 0.06 9.78 0.07 0.03 4.48 0.04
 Step time (s) 0.04 7.70 0.05 0.04 7.22 0.05
 Single support time (s) 0.03 7.14 0.04 0.03 6.91 0.04
 Double support time (s) 0.03 15.23 0.04 0.03 12.77 0.04
Temporophasic parameters
 Stance percentage (%GC) 1.97 3.31 2.36 1.60 2.63 1.92
 Single support percentage (%GC) 2.56 6.34 3.07 2.49 6.32 2.99
 Double support percentage (%GC) 2.18 11.42 2.62 2.30 10.71 2.76
Temporospatial parameters
 Gait speed (m/s) 0.02 1.58 0.02 0.02 1.75 0.02
 Normalized gait speed 0.04 9.20 0.05 0.04 10.34 0.05
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Double support time and those parameters expressed as a percentage of the gait cycle 
(especially double support percentage) showed the largest relative differences and/or 
worst ICCs in both participant groups. Similar results have been reported recently in 
a study validating a three-IMU system relative to an instrumented walkway [25]. Errors 
for double support time and percentage, and single support percentage, tended to be 
lower in PLHIV relative to SNP. These differences may stem from gait speed differences 
and/or true pathology [25], although further research is needed to support such specula-
tions. Other IMU validation studies comparing (slower walking) older adults to (faster 
Table 4 Absolute reliability (measurement error) of kinematic angles measured by inertial 
measurement units
A1 corresponding to A1 power phase of ankle, A2 corresponding to A2 power phase of ankle, H3 corresponding to H3 
power phase of hip, HR heel rise, IC initial contact, K1 corresponding to K1 power phase of knee, K2 corresponding to K2 
power phase of knee, K3 corresponding to K3 power phase of knee, LR loading response, MSt mid-stance, PLHIV people 
living with HIV-1 infection, ROM range of motion, SEM standard error of measurement, SNP HIV-seronegative participants, 
TO toe-off, TSt terminal stance
Angle/ROM (degrees) SNP PLHIV
SEM Upper 95% CL SEM Upper 95% CL
Pelvis
 Pelvis tilt ROM 0.7 0.8 0.8 1.0
 Peak pelvis anterior tilt 1.1 1.3 1.2 1.4
 Pelvis obliquity ROM 0.9 1.1 1.1 1.3
 Pelvis rotation ROM 2.1 2.5 1.8 2.2
 Pelvis rotation, IC 5.2 6.2 3.7 4.4
Hip
 Hip flexion ROM 2.4 2.9 2.1 2.5
 Hip flexion ROM, LR 1.7 2.0 2.6 3.1
 Hip flexion ROM, PS to IS (H3) 2.3 2.8 2.0 2.4
 Hip flexion, IC 2.4 2.9 2.1 2.5
 Peak hip flexion, swing 2.2 2.6 2.1 2.5
 Peak hip extension, stance 1.8 2.2 2.4 2.9
 Hip abduction ROM, mid-stance 2.6 3.1 2.0 2.4
 Hip adduction ROM, LR 1.4 1.7 1.5 1.8
 Hip internal rotation ROM 2.6 3.1 2.8 3.4
Knee
 Knee flexion ROM 1.4 1.7 2.2 2.6
 Knee flexion ROM, stance (K1) 2.9 3.5 2.5 3.0
 Knee flexion ROM, stance to swing (K3) 3.0 3.6 2.8 3.4
 Knee extension ROM, MSt to TSt (K2) 1.9 2.3 2.4 2.9
 Knee flexion, IC 3.0 3.6 3.2 3.8
 Peak knee flexion during stance, LR 3.9 4.7 5.8 7.0
 Peak knee extension, stance 2.9 3.5 3.1 3.7
 Peak knee flexion, swing 2.0 2.4 2.9 3.5
Ankle
 Ankle dorsiflexion ROM, stance (A1) 2.0 2.4 1.9 2.3
 Ankle dorsiflexion ROM, swing 2.9 3.5 3.3 4.0
 Ankle plantarflexion ROM, push off (A2) 2.2 2.6 3.7 4.4
 Ankle dorsiflexion, IC 2.0 2.4 2.1 2.5
 Ankle plantarflexion, TO 5.2 6.2 4.4 5.3
 Peak ankle plantarflexion 4.1 4.9 4.4 5.3
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walking) younger adults have had similar findings for these parameters (lower errors for 
these outcomes in the older adults) [25, 26].
Differences between the IMU and OMC systems were more apparent when com-
paring (discrete) kinematic angles at specific time points of the gait cycle, and less so 





Fig. 3 Comparative gait traces for people living with HIV (PLHIV) and HIV-seronegative participants (SNP). 
Sagittal plane kinematic traces are shown as measured by optical motion capture (OMC) (a–d) and inertial 
measurement units (IMUs) (e–h). The graphs illustrate the mean (solid lines) ± standard deviation (shaded 
areas bounded by dashed lines) estimated by each system for each group. Note similarities in magnitude and 
direction of differences between PLHIV and SNP as observed by each system
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Considering the different technology sources (IMUs versus cameras) as well as models 
to measure and calculate kinematic angles, these results are not surprising and gener-
ally agree with previous studies comparing IMU and OMC technologies [27, 28]. Low 
RMSE and excellent correlations have for example been reported for most lower limb 
joints during gait when either using the same biomechanical model to calculate angles 
from IMU segment position data and OMC marker clusters (RMSE below 5°), or after 
removing the offset between models (RMSE below 9°) [27, 29, 30]. When however using 
independent models without offset correction to calculate IMU and OMC kinematics, 
correlations remained good to excellent while worse RMSE (e.g., up to 28° for the hip) 
were demonstrated in these studies [27, 30]. Our results reaffirm previous observations 
that discrete angles are not directly comparable between IMU and OMC systems/mod-
els, while relative angular ROM seem more comparable [27]. These observations may 
largely stem from the different ways that segment positions and joint axes definitions are 
established during the systems’ respective calibrations—this would be especially true for 
the sagittal plane. In addition to between-system differences in segment positions and 
joint axes definitions, soft tissue artifact may affect marker and IMU positions in differ-
ent ways; further increasing differences between the systems/models [31].
Table 5 Gait parameter differences between  people with  and  without HIV as  measured 
by the respective systems
Asterisks indicate statistically significant differences between participant groups
%GC percentage of gait cycle, IMU inertial measurement units, OMC optical motion capture
Parameter Mean difference 95% CI p‑value Mean difference 95% CI p‑value
IMU OMC
Spatial parameters
 Step length (cm) 2.29 − 2.92; 7.50 0.36 2.60 − 1.9; 7.1 0.24
 Normalized step 
length
0.05 − 0.03; 0.13 0.19 0.10 0.0; 0.1 0.09
 Stride length (cm) 5.31 − 5.11; 15.73 0.29 5.62 − 3.52; 14.76 0.21
 Normalized stride 
length




7.71 − 2.11; 17.54 0.11 7.34 − 2.41; 17.09 0.13
 Stance time (s) − 0.06 − 0.11; 0.00 0.04* − 0.06 − 0.11; 0.00 0.04*
 Step time (s) − 0.04 − 0.09; 0.01 0.12 − 0.04 − 0.09; 0.01 0.11
 Single support 
time (s)
− 0.02 − 0.06; 0.03 0.41 − 0.02 − 0.06; 0.02 0.37
 Double support 
time (s)
− 0.04 − 0.07; − 0.01 0.01* − 0.04 − 0.06; − 0.02 < 0.01*
Temporophasic parameters
 Stance time (%GC) − 1.41 − 2.90; 0.09 0.06 − 1.29 − 2.13; − 0.45 0.01*
 Single support time 
(%GC)
0.99 − 0.65; 2.62 0.22 1.06 0.20; 1.92 0.02*
 Double support 
time (%GC)
− 2.39 − 5.34; 0.56 0.10 − 2.35 − 3.97; − 0.73 0.01*
Temporospatial parameters
 Gait speed (m/s) 0.12 − 0.02; 0.26 0.09 0.13 0.00; 0.27 0.06
 Normalized gait 
speed
0.05 0.00; 0.10 0.06 0.05 0.00; 0.10 0.03*
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Table 6 Kinematic differences between  people with  and  without HIV as  measured 
by the respective systems
Kinematic angle Mean difference 95% CI p‑value Mean difference 95% CI p‑value
IMU OMC
Ankle
 Ankle dorsiflexion ROM 
during stance (A1)
− 0.3° − 4.1°; 3.5° 0.87 − 0.6° − 4.7°; 3.5° 0.76
 Ankle dorsiflexion ROM 
during swing
6.4°* − 1.2°; 13.9° 0.09 6.4°* − 0.6°; 13.4° 0.07
 Ankle plantarflexion 
ROM during push 
off (A2)
4.3° − 2.3°; 11.0° 0.18 6.1°* − 0.3°; 12.4° 0.06
 Ankle dorsiflexion 
angle at IC
− 1.5° − 4.8°; 1.9° 0.36 − 1.2° − 4.2°; 1.8° 0.42
 Ankle plantarflexion 
angle at TO
4.6° − 2.1°; 11.4° 0.16 5.6°* 0.0°; 11.3° 0.05
 Peak ankle plantarflex-
ion during GC
5.9°* − 1.6°; 13.4° 0.11 7.2°* 0.2°; 14.3° 0.05
Knee
 Knee flexion ROM dur-
ing GC
2.6° − 3.3°; 8.4° 0.36 3.6° − 1.4°; 8.6° 0.15
 Knee flexion ROM dur-
ing stance (K1)
0.3° − 4.7°; 5.4° 0.90 − 0.6° − 5.4°; 4.3° 0.80
 Knee flexion ROM from 
stance to swing (K3)
3.9° 0.0°; 7.8° 0.05 4.1° 0.2°; 8.1° 0.04*
 Knee extension ROM, 
MSt to TSt (K2)
2.7° − 2.3°; 7.8° 0.26 1.8° − 3.5°; 7.1° 0.47
 Knee flexion at IC 0.0° − 5.3°; 5.3° 1.00 0.1° − 4.1°; 4.4° 0.95
 Peak knee flexion dur-
ing stance, LR
− 1.1° − 6.8°; 4.6° 0.69 − 1.8° − 7.3°; 3.7° 0.49
 Peak knee extension 
during stance
1.0° − 3.4°; 5.5° 0.63 1.7° − 1.6°; 5.0° 0.30
 Peak knee flexion dur-
ing swing
1.9° − 0.8°; 4.6° 0.16 2.0° − 0.5°; 4.6° 0.11
Hip
 Hip flexion ROM during 
GC
4.6° 0.2°; 9.0° 0.04* 2.6° − 1.5°; 6.7° 0.19
 Hip flexion ROM dur-
ing LR
− 1.2° − 3.5°; 1.1° 0.28 − 0.4° − 2.7°; 1.8° 0.69
 Hip flexion ROM, PS to 
IS (H3)
0.4° − 3.1°; 3.8° 0.83 − 1.2° − 3.4°; 1.1° 0.28
 Hip flexion angle at IC − 0.66° − 10.4°; 9.3° 0.90 − 0.8° − 9.3°; 7.8° 0.85
 Peak hip flexion during 
swing
0.7° − 8.4°; 9.7° 0.87 − 0.8° − 8.4°; 6.9° 0.84
 Peak hip extension dur-
ing stance
3.7° − 5.2°; 12.7° 0.39 3.3° − 4.8°; 11.5° 0.397
 Hip abduction ROM 
during mid-stance
− 0.4° − 3.4°; 2.6° 0.79 2.8° 0.9°; 4.8° 0.01*
 Hip adduction ROM 
during loading 
response
1.6° − 1.2°; 4.4° 0.24 1.3° − 0.7°; 3.2° 0.18
 Hip internal rotation 
ROM during GC
1.1° − 3.1°; 5.3° 0.59 2.1° − 1.9°; 6.0° 0.28
Pelvis
 Pelvis tilt ROM during 
GC
0.5° − 1.9°; 3.0° 0.65 0.7° − 0.4°; 1.9° 0.20
 Peak pelvis anterior tilt 
during GC
− 1.6° − 9.6°; 6.3° 0.66 − 1.4° − 8.6°; 5.8° 0.69
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In both participant groups, TSP demonstrated acceptable-to-excellent reliability 
(except for three parameters), with measurement errors smaller than what would be con-
sidered clinically meaningful. For example, the SEM for gait speed—an outcome com-
monly measured in clinical function studies in PLHIV [9] —was 0.02 m/s (SEM% < 2%) 
in both groups, whereas a much larger value of 0.1 m/s has been suggested as being clin-
ically significant [32]. In terms of measurement error for TSP, less reliable results were 
observed for stance time in SNP and single support percentage in both groups. Poten-
tial reasons may be that these outcomes were truly unstable, or an insensitivity of the 
IMU technology to detect a relatively stable phenomenon. In a study by Washabaugh 
and colleagues [24], where measurement error that is due to natural walking variations 
was controlled for by means of treadmill walking, stance and swing percentages were the 
least reliable TSPs measured by foot-mounted IMUs—suggesting larger instrumentation 
error for these outcomes.
We found that the trends in reliability of IMU-measured kinematic angles were gener-
ally similar between PLHIV and SNP groups and fair-to-excellent for all but three angles 
(pelvis rotation at initial contact in both groups, ankle plantarflexion at toe-off in PLHIV 
and peak knee flexion in stance in SNP). The worse findings for these discrete outcomes 
may suggest that some key events of the gait cycle are inherently more variable in the 
groups, or that the IMU- and OMC-systems were both more susceptible to, and poten-
tially affected in different ways by, soft tissue artifact at these events; considering arti-
facts reported for the pelvis (high, up to 25 mm), thigh (high: up to 31 mm) and lateral 
malleolus (moderate: up to 15 mm) [33]. The relative error of these moderate-to-high 
soft tissue artifacts will be even larger for motions with small ranges (i.e., low signal-to-
noise ratios) [23].
For all other joint/segments and planes, ICC values of between 0.76 and 0.99 were 
observed, with a relatively small SEM (≤ 4.4°). These results are comparable to published 
results for within-rater or between-trial reliability for OMC [20] and IMU systems [17, 
34]. According to a recent systematic review [17], reliability for IMU-measured kinemat-
ics across lower limb joints and planes ranged from 0.40 to 0.95 in terms of correlation 
coefficients and 0.3°–9.9° in terms of absolute errors. However, the authors noted that 
the small number of studies for each joint did not allow for strong conclusions (e.g., 
only one study reporting pelvic angles). Most reports of IMU-based systems have not 
Table 6 (continued)
Kinematic angle Mean difference 95% CI p‑value Mean difference 95% CI p‑value
IMU OMC
 Pelvis obliquity ROM 
during GC
1.2° − 2.0°; 4.4° 0.44 3.5° − 0.4°; 7.5° 0.08
 Pelvis rotation ROM 
during GC
0.6° − 6.2°; 7.4° 0.85 1.4° − 4.0°; 6.8° 0.60
 Pelvis rotation at IC 0.5° − 2.8°; 3.9° 0.74 0.7° − 2.9°; 4.3° 0.68
Asterisks indicate clinically and/or statistically significant differences between participant groups
A1 corresponding to A1 power phase of ankle, A2 corresponding to A2 power phase of ankle, H3 corresponding to H3 
power phase of hip, HR heel rise, IC initial contact, K1 corresponding to K1 power phase of knee, K2 corresponding to K2 
power phase of knee, K3 corresponding to K3 power phase of knee, LR loading response, MSt mid-stance, PLHIV people 
living with HIV-1 infection, ROM range of motion, SEM standard error of measurement, SNP HIV-seronegative participants, 
TO toe-off, TSt terminal stance
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reported the reliability of discrete joint angles; we expand on the existing body of litera-
ture in this regard.
In clinical terms, it may be more important to consider absolute rather than relative 
reliability when interpreting the results for 3D gait analysis—i.e., whether the measure-
ment error renders the instrument meaningful for clinical use [35]. Although the ICC 
has been widely recommended to assess reliability, it has the disadvantage of being 
affected by between-participant variability (unlike the SEM). In  situations where little 
variation exists between participants, the ICC will inevitably be low or unmeasurable 
(as was the case for pelvic obliquity in this study, when calculating an ICC for compar-
ing IMUs and OMC), since it measures the ratio of within-participant variability to 
between-participant variability [36]. A further example of this limitation is peak knee 
flexion during stance in SNP, which had a poor ICC of 0.45 but a clinically acceptable 
SEM of 3.9°. Similarly, the low ICC of pelvis rotation at initial contact was also associ-
ated with an acceptable SEM (3.7°) in PLHIV.
When interpreting IMU and OMC data separately to compare gait patterns between 
PLHIV and SNP, the magnitude and direction of between-group differences (both sig-
nificant and non-significant) were similar for the two systems. Slowed gait speed—the 
most consistently reported finding from clinical gait studies in PLHIV [9]—was dem-
onstrated by both systems in terms of clinical but not statistical significance [between-
group differences of > 0.10 m/s demonstrate by both systems—exceeding the minimum 
clinically important difference (MCID) reported for usual-paced gait [32]—but p-values 
for both systems exceeded 0.05]. Both systems also detected significantly increased 
stance- and double support times in PLHIV (p < 0.05), as well as clinically significantly 
decreased ankle joint angles in PLHIV (between-group differences exceeding 5°). From 
a gait analysis point of view, these results support the sensitivity of IMUs to the differ-
ences between populations on the level of what an HIV-associated deviation might be. 
As expected, the kinematic differences between PLHIV and SNP in this relatively young 
sample were mostly small—although the magnitude of biomechanical differences that 
would translate into functional limitations in PLHIV remains unknown and an area for 
future research.
Clinical implications
The validity and reliability of IMU-based gait analyses are not compromised by the pres-
ence of HIV. Firstly, this study showed similar trends in validity and reliability in both 
participant groups. Absolute reliability results indicate a sufficiently low level of meas-
urement error for IMUs to be used for clinical interpretation, and values fall well within 
the precision error reported for OMC [20]. Secondly, despite the differences in data 
sources and modeling employed by OMC and IMUs, our results suggest that similar 
clinical conclusions may be drawn when using either system for clinical gait analysis in 
PLHIV (e.g., both systems demonstrated the expected kinematic and TSP changes that 
would logically accompany slow gait in PLHIV relative to SNP). It was not the aim of this 
paper to describe the deviations potentially occurring in PLHIV, but rather to explore 
whether an IMU system would be sensitive enough to detect small effects between 
groups in a similar manner to OMC; indeed this seems to be the case. It should be kept 
in mind, however, that different IMU systems use different algorithms and because of 
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an inherent offset between IMU- and OMC systems/models, data from IMU and OMC 
systems should not be used interchangeably.
Limitations
A study limitation is that only usual-paced walking was assessed, and thus study results 
are not generalizable to very slow or fast speeds. The accuracy of IMUs are reportedly 
the highest in the range of 1.0–2.2 m/s, and lower at velocities that are either slower or 
faster than this range [37]. The performance of IMUs when conducting gait analysis in 
PLHIV should be verified in such speed ranges. Although IMUs proved to be suited to 
the specific population used in this project, these results may not readily be assumed to 
hold true in different populations with gross gait pathology or higher BMI. Although 
OMC served as reference standard, it is susceptible to faulty marker placement [38]; 
nevertheless, marker-placement by a laboratory-trained physiotherapist likely limited 
marker placement errors.
Conclusion
To conclude, this study demonstrated valid and reliable results from an IMU system for 
3D gait analysis, delivering a wide range of clinically relevant gait outcomes in people 
with and without HIV. Despite the different data sources and modeling used by IMU 
and OMC systems, a gait analysis conducted in a unique population, namely PLHIV, 
provided similar magnitudes and directions of differences relative to healthy individuals, 
and thus similar clinical conclusions are likely when using either system.
Methods
Participants
Eight PLHIV and eight SNP were recruited from a public primary care community 
health center (Table  7). Eligibility criteria included: (1) age 18 to 65; (2) BMI < 25  kg/
m2; (3) independent ambulatory function; and (4) ability to consent and participate in 
study procedures. Exclusion criteria were: (1) pregnancy; (2) acute opportunistic infec-
tion or illness; (3) peripheral neuropathy; (4) history of major neurological conditions; 
(5) neuromusculoskeletal impairments or injury affecting usual gait; (6) visual impair-
ment; or (7) acute alcohol consumption. Participants had to have a confirmed laboratory 
test result of HIV status. The research was in accordance with the Helsinki Declaration 
and ethical approval was granted by the Stellenbosch University Human Research Eth-
ics Committee (N15/05/043). Written informed consent (including HIV testing con-
sent) was obtained from participants. Pre- and post-test counselling was offered where 
needed.
Study design
This study incorporated concurrent validity testing and within-session, between-trial 
repeated measures reliability testing. Concurrent validity refers to a form of criterion 
validity where the performance of two different measures is assessed at the same time 
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to determine the similarity between the index test/new measure (IMUs in this case) 
and the criterion measure/reference standard (OMC in this case). Reliability refers to 
the extent to which repeated measures provide similar results in unchanging individuals 
[39] and was determined in this study across multiple repeated trials, which all occurred 
during a single session. A single testing session was thus conducted per participant and 
a single rater (motion analysis-trained physiotherapist) performed all testing. The study 
formed part of a larger protocol to study gait features in PLHIV residing in a semi-rural 
South African setting.
Setting
Data were collected in the Stellenbosch University Central Analytical Facilities (CAF) 
3D Human Biomechanics Unit, Tygerberg Medical Campus, Cape Town, South Africa. 
Participants were transported between the clinic and the motion laboratory using offi-
cial university transport services.
Sample size
Sample size was based on the SEM (a measure of intra-individual variability) for lower 
limb kinematic angles across the gait cycle, considering a reported SEM of 4.1° [40]. This 
was the maximum SEM (hip rotation) reported across tri-planar lower limb angular 
ROM in healthy adults for usual-paced walking [40]. An MCID of 5° is suggested for 
lower limb gait kinematics [41]. To establish that a measured SEM of 4.1° is lower than 5° 
at a one-sided 95% confidence interval (CI), the recommendations by Stratford and 












= 1.5 . 
Using this variance ratio and Table 7 in [42], the required sample size was estimated for a 
protocol making use of 6 measurements per participant; i.e., a sample size of 9 partici-
pants. Sample size was restricted by pragmatic constraints such as participant transpor-
tation; thus, a convenience sample of 8 PLHIV and 8 SNP was deemed practical.
Table 7 Sample description
BMI body mass index, ART antiretroviral therapy, PLHIV people living with HIV-1 infection, SNP HIV-seronegative participants
Characteristic SNP (n = 8) PLHIV (n = 8) p‑value
Age in years, mean (SD) 28.84 (8.11) 36.61 (9.44) 0.10
Female sex, n (%) 6 (75) 4 (50) 0.30
Height (m), mean (SD) 1.59 (0.09) 1.64 (0.08) 0.20
Weight (kg), mean (SD) 49.51 (11.24) 57.23 (9.99) 0.17
BMI (kg/m2), mean (SD) 19.54 (3.03) 21.19 (3.50) 0.33
Leg length (cm), mean (SD) 84.72 (5.52) 85.86 (4.40) 0.65
Most recent CD4+ T-cell count (cells/µL), mean (SD) – 558.25 (181.80) –
Detectable viral load (> 50 cp/mL), n (%) – 6 (75) –
Years since HIV diagnosis, n (%) –
 < 2 years – 4 (50) –
 2–5 years – 2 (25) –
 5–15 years – 1 (12.5) –
 > 15 years – 1 (12.5) –
On ART, n (%) – 6 (75) –
ART duration in weeks, median (IQR) – 71.50 (16.00–465.00) –
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Instrumentation and procedures
IMUs and reflective OMC markers of two independent gait analysis systems were fix-
ated simultaneously on the participant (Fig. 4) to collect gait data concurrently using the 
two systems and their respective biomechanical models.
Inertial measurement unit (IMU) system
The index test was a wireless IMU system (myoMOTION Research Pro, Noraxon 
USA Inc.) consisting of a receiver and 7 IMUs (for a lower body setup). Each IMU 
(37.6 mm × 52.0 mm × 18.1 mm; 34 g) has a local coordinate system and measures accel-
erations and yaw-pitch-roll orientations along three coordinate axes. IMUs were placed 
on body segments according to a rigid lower body model provided by the IMU system 
software [myoRESEARCH 3.10.64 (MR3)]. The model considers each body segment as 
a rigid unit with interlinking joints and assumes a rigid IMU-segment attachment. The 
system was calibrated before conducting measurements using a neutral standing pose. 
Gait events (initial contact and toe-off) were detected using an IMU-based contact 
detection algorithm provided by the software. The algorithm utilizes gyroscope (foot 
angular velocity) as well as acceleration measurements from the foot-mounted IMU to 
identify periods when the foot is in contact with the ground, creating virtual foot contact 
signals for each foot. A sampling rate of 200 Hz was selected for all IMUs. Our labora-
tory previously demonstrated the capability of the IMUs to measure angles with a static 
accuracy of 0.4° ± 0.2° (inclination) and 0.8° ± 0.4° (heading) and dynamic accuracy of 
0.9° ± 0.2° (inclination) and 2.0° ± 0.8° (heading). Acquired motion-related signals (IMU 
data) were transmitted wirelessly by a small radio module to a recording laptop.
Fig. 4 Marker and inertial measurement unit (IMU) placement
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Optical motion capture (OMC) system
The reference standard was an OMC system (MX T-series, VICON Motion Systems 
Limited) and the Plug-in-Gait (PiG) model. The system uses multiple synchronized high-
resolution, high-speed cameras to reconstruct body posture and provides body segment 
position (origin) and orientation (axis directions) relative to a global fixed coordinate 
system. The VICON has previously demonstrated high validity and reliability [43], and 
the Conventional Gait Model (implemented as PiG) constitutes the most widely used 
and validated biomechanical model in clinical research [44]. This study used 8 infrared 
tripod VICON T-20 cameras with Nexus 1.8.5 software. The system captured data at 
200 Hz. Twenty-two passive retro-reflective markers (14 mm diameter) were placed on 
anatomical landmarks and biomechanical outcomes were calculated according to a vali-
dated modified lower body PiG model provided by the OMC software. Gait events were 
detected using a time-synchronized, floor-embedded force plate system (Model FP9060-
15, Bertec Corporation, Ohio, USA). The OMC capture volume was calibrated prior to 
data collection.
Participant preparation and biomechanical model calibration
Anthropometric measurements were taken as required for the respective systems’ mod-
els (height and weight for both systems; leg length from anterior superior iliac spine 
(ASIS) to medial malleolus and knee- and ankle width for OMC). Markers and IMUs 
were then placed on the participant simultaneously (Fig. 4). First, 22 OMC markers were 
placed on bony landmarks according to the PiG model, i.e., bilaterally on the heel (cal-
caneus at the same height above the plantar foot surface as the toe marker), medial and 
lateral malleolus, second metatarsal (mid-foot side of equinus break), shank (aligned 
with the ankle flexion axis), tibial tuberosity, medial and lateral knee (flexion/extension 
axis), lateral thigh (lower lateral one-third surface), anterior superior iliac spine and 
posterior superior iliac spine. Markers were not removed during any trials. IMUs were 
subsequently placed on the sacrum and bilaterally on the lateral thigh (lower segmental 
quadrant, i.e., the area of lowest muscle belly displacement during walking), shank (ante-
rior and slightly medial to be placed along the tibia), and foot (dorsally and sufficiently 
proximal to the equinus break to avoid excessive IMU motion) using double-sided tape 
and Velcro straps. IMU foot-placements were reinforced with elastic adhesive bandage. 
Participants performed practice trials to familiarize themselves with testing procedures. 
During practice trials, starting positions for optimal force plate foot strikes were noted, 
and enough trials were allowed for the rater to be satisfied that a relaxed, normal gait 
was assumed.
Static anatomical OMC calibration was subsequently performed with the participant 
standing on the force plate according to standard laboratory protocol (once off per par-
ticipant and prior to IMU calibration). Next, the IMU model was calibrated as per the 
manufacturer’s instructions by having the participant stand stationary in a neutral ref-
erence posture. The calibration was performed on a 30  cm-high wooden platform to 
mitigate potential floor-based magnetic distortions. As frequent IMU calibration within 
test series is recommended [45] to avoid drift over time, the IMU system was calibrated 
repeatedly (directly prior to each gait trial). We previously demonstrated within-rater 
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reliability for this calibration pose and procedure (SEM 0.3°–2.2°; Berner, K., Cockcroft, 
J., Morris, L., & Louw, Q., under review).
Gait analysis protocol
Each session consisted of a neutral-pose IMU calibration, directly followed by a bare-
footed walking trial during which IMU and OMC data were recorded simultaneously. 
Participants had to walk at a self-selected usual speed along a straight 10-m walkway 
with the force plate system embedded midway. Participants started walking approxi-
mately 1 m before a taped line on the floor and ended after crossing a second line. Time 
synchronization between the two systems was performed automatically using alignment 
of a hardwire synchronization pulse (5 V TTL signal). A gait trial was deemed successful 
if the participant’s entire landing foot contacted at least one force plate without obvious 
targeting. Gait trials were performed in the same direction each time and after each trial, 
the participant returned to the wooden platform immediately for the next IMU calibra-
tion. Trials continued until good-quality data for 6 trials (3 left- and 3 right-footed force 
plate strikes) were obtained.
Data processing
The IMU system software automatically filtered raw data using a robust fusion algorithm 
(Kalman filter) optimized for IMU data. Angular orientations were estimated at IMU 
level by combining the elemental sensor component axes readings into four element 
quaternion values. Segment dimensions of the model were calculated in the IMU soft-
ware using participant height to estimate anthropometric dimensions. For the determi-
nation of distance-related outcomes, the following applied: the IMU software estimated 
model translation over the ground using a forward kinematics technique together with 
sequential pinning of the foot segments onto the ground during the contact phase. The 
bone segment lengths on the biomechanical model were scaled to the participant dimen-
sions. Then, using their measured orientations and known lengths, the interconnected 
lower limb segments were positioned in space in a kinematic chain, which translates the 
model forwards from foot contact to subsequent foot contact. Outcomes such as step 
length were then extracted from the position of virtual landmarks on the foot segments.
Pre-processing of OMC gait trials was done in Nexus software. Marker trajectories 
were reconstructed and labeled using standard functions, then smoothed with a fourth-
order, zero-lag low-pass Butterworth filter (6 Hz cut-off) [46]. Joint and segment kin-
ematics were calculated using the standard dynamic PiG pipeline, which determines 
hip joint centers using the Davis equations [47]. Knee axis estimation was performed 
by optimizing the thigh-rotation offset parameter during gait [48], and ankle axis esti-
mation by determining the shank-rotation offset parameter during the static trial using 
medial and lateral malleolus markers. OMC gait events were detected from force plate 
data (20 N threshold).
Data recorded in the IMU and OMC software were, respectively, exported to single 
.csv and .c3d files and imported into MATLAB software (R2017a, MathWorks). In cases 
where a gait trial contained more than one complete and valid gait cycle for one or both 
legs, only the gait cycle for each leg judged to contain the best data quality was retained 
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for analysis. The cyclical gait events from each system (initial contact and toe-off) were 
used to segment trial data into cycles normalized in time to 101 data points at 1%-time 
intervals. Gaps in gait trajectories were inspected and filled and IMU and OMC out-
comes were determined using custom analysis scripts, including the construction of 
visualizations. Although the IMU biomechanical model is based on the standards for 
joint rotations sequences as set by the International Society of Biomechanics (ISB), some 
differences in conventions exist regarding polarity. Thus, opposing angular polarities in 
IMU output were manually inverted according to the positive definitions of each angular 
motion before determining IMU outcomes. Finally, using a macro routine, all outcomes 
were exported to MS Excel for further analysis.
Data outcomes and analysis
Using the average of both lower limbs, TSP (temporal, spatial, temporophasic and tem-
porospatial parameters) and kinematic angular outcomes were selected based on clini-
cal relevance in discriminating elderly and/or fall-prone gait [49]. Kinematics included 
ROM (difference between the maximum and minimum angle during gait cycle) and key 
point values (angular values at specific time points of gait cycle). Performance of the 
IMU system’s event-detection algorithm was evaluated by calculating the average detec-
tion offset [difference in milliseconds (ms) between IMU- and OMC-detected events] 
for initial contact and toe-off. Detection offsets were averaged across all participants and 
converted from frames per second to seconds using the sampling rate of the system, and 
then converting the result to ms. Extraction of kinematic key points from the time-nor-
malized average of each assessment was performed using a customized routine in MAT-
LAB, based on key event and phase definitions listed in Additional file 1.
Statistical analysis
Statistical analysis was performed using MS Excel V16.12 (Bland–Altman and LoA) 
and IBM SPSS Statistics 25.0 (SPSS Inc., Chicago, IL, USA) (all other analyses). 
Between-group differences were assessed using independent t-tests (separately for 
each system). Statistical significance was set at p < 0.05. An MCID of > 5° [20] was 
considered clinically significant for kinematic angles, while clinically significant dif-
ferences for TSP were interpreted in terms of percentage differences and reported 
MCIDs from the literature, where available.
Concurrent validity
Concurrent validity between the mean gait outcomes measured by the two systems 
was assessed by calculating ICCs (two-way mixed, mean rating) with 95% CIs. Bland–
Altman bias (indicative of magnitude-dependent systematic difference) and 95% LoA 
(representing limits around the mean difference within which 95% of observed differ-
ences lie) were calculated. Absolute offset error between IMU- and OMC-measured 
outcomes was assessed using RMSE. To aid clinical interpretation of TSP, mean abso-
lute percentage errors were calculated.
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Within‑session reliability
Relative within-session reliability of IMU-measured gait outcomes was assessed by using 
all six trials for each outcome and calculating ICCs (two-way mixed effects, single rater/
measurement) with 95% CIs. Absolute reliability was quantified using SEM, calculated 
as the square root of the mean-square-error  (MSE) from a two-way repeated-measure 
analysis of variance (ANOVA). This approach is robust to between-participant variabil-
ity and thus preferable to SEM calculations based on the ICC [19]. The upper 95% CL of 
the SEM was calculated according to [19] by multiplying the SEM by a multiplying fac-
tor determined according to the number of participants and trials (1.2 in this study). For 
TSP, absolute %SEM was additionally calculated to aid interpretation.
The ICC is an index ranging from 0 to 1 that reflects both degree of correlation 
and agreement between measurements within a class of data. ICCs were interpreted 
as poor (ICC < 0.60), questionable (0.60 ≤ ICC < 0.70), acceptable (0.70 ≤ ICC < 0.80), 
good (0.80 ≤ ICC < 0.90) or excellent (ICC ≥ 0.90) [50]. Absolute agreement criteria 
were used for all ICCs. To interpret mean absolute percentage error and %SEM, a 
classification criterion of acceptability was used based on standard statistical thresh-
olds for significance analysis [51]. It was also considered that a reference threshold of 
5% has been proposed for accuracy error in step length and distance [51]. The follow-
ing categories were considered: excellent (< 5%), good (5% to < 10%), sufficient (10% to 
< 20%) and unacceptable (20% or higher) [51].
Supplementary information
Supplementary information accompanies this paper at https ://doi.org/10.1186/s1293 8-020-00802 -2.
Additional file 1. Delamination and definition of gait phases, including defining events. Key event and phase defini-
tions used in the customized MATLAB routine to extract kinematic key points and phases from the time-normalized 
average of each assessment.
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